India Glycols Limited (IGL) has reported robust financial results for the first quarter, with significant growth across key segments. The company's performance was particularly strong in its Bio-Fuels and Potable Spirits divisions, contributing to an overall increase in profitability.

Financial Highlights

Segment Performance

Bio-Fuels

The Bio-Fuels segment emerged as a key growth driver, with revenue increasing by 45% to Rs. 348.00 crores. This segment's EBIT margin stood at 6.50%.

Potable Spirits

The Potable Spirits division also demonstrated strong performance:

• Revenue grew by 22% to Rs. 342.00 crores
• EBIT margin improved significantly from 17.50% to 21.10%

Chemicals

While the Chemicals segment faced some pressure with revenue declining to Rs. 300.00 crores, its EBIT margin expanded from 9.90% to 10.90%.

Ennature Biopharma

The Ennature Biopharma segment experienced challenges, with both sales and margins under pressure.

Joint Venture Performance

IGL's joint venture with Clariant showed remarkable improvement:

• JV's sales grew by approximately 15-16%
• IGL's share of profit from the JV increased by 73.70% year-on-year to Rs. 19.00 crores
• EBITDA growth for the JV was around 40%

Strategic Developments

1. Restructuring Initiative: IGL is undergoing a restructuring process to create separate entities for different business segments, aiming to enhance shareholder value.

2. Expansion Plans: The company is expanding into new geographies, including Kerala, for its liquor business.

3. Premium Brand Focus: IGL is strengthening its premium liquor portfolio through partnerships, such as with Amrut Distilleries.

4. Performance Chemicals Growth: The company reported significant growth in its new value-added Performance Chemicals business, with plans for incremental capacity expansions.

5. Bio-Fuel Strategy: IGL continues to align with the government's ethanol blending program, which is on track to achieve 20% blending by 2025-26.

Management Commentary

Rupark Sarswat, CEO of India Glycols Limited, commented on the results: "We have had a good quarter with strong performance across key segments. Our Bio-Fuels and Potable Spirits businesses have shown excellent growth, while we continue to focus on value-added products in our Chemicals segment. The joint venture with Clariant has also contributed significantly to our overall results."

Future Outlook

The company remains optimistic about its growth prospects, particularly in the Bio-Fuels and Potable Spirits segments. IGL is also focusing on improving its product mix in the Chemicals business and addressing challenges in the Ennature Biopharma segment through differentiation and expansion into regulated markets.

India Glycols Limited continues to leverage its diverse portfolio and strategic initiatives to drive growth and profitability in a dynamic market environment.

India Glycols Limited (IGL) has successfully executed a share sub-division, effectively doubling the number of outstanding shares while halving their face value. This corporate action, aimed at enhancing the stock's liquidity and accessibility, has been completed with the new shares credited to shareholders' accounts.

Key Details of the Share Sub-Division

• Pre-Split: Each equity share had a face value of Rs. 10
• Post-Split: Each original share split into two shares with a face value of Rs. 5 each
• New ISIN: INE560A01023 (replacing the old ISIN INE560A01015)
• Record Date: August 13, 2025

Impact on Share Capital

The share sub-division has resulted in significant changes to IGL's share structure, while maintaining the overall share capital value:

Execution and Confirmation

India Glycols Limited has received confirmations from both the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) regarding the successful credit of the sub-divided shares. The corporate action was executed through MCS Share Transfer Agent Limited, the company's Registrar and Transfer Agent.

According to the CDSL confirmation, a total of 45,620,032 new equity shares were credited to 32,482 shareholder records on August 13, 2025. Simultaneously, 23,234,164 shares under the old ISIN were debited.

Regulatory Compliance

In compliance with regulatory requirements, India Glycols Limited has duly informed the BSE Limited and the National Stock Exchange of India Limited about the completion of this corporate action. The company has also updated this information on its official website at www.indiaglycols.com .

This share sub-division is expected to improve the stock's liquidity in the market, potentially making it more accessible to a broader range of investors. However, it's important to note that while the number of shares has increased, the fundamental value of shareholders' holdings remains unchanged.